Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from Proteomics International Laboratories Ltd. ( (AU:PIQ) ).
Proteomics International Laboratories Ltd has announced the quotation of 20,356,556 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of June 6, 2025. This move is part of previously announced transactions and reflects the company’s ongoing efforts to enhance its market presence and operational capabilities, potentially impacting its stakeholders by increasing liquidity and investment opportunities.
The most recent analyst rating on (AU:PIQ) stock is a Sell with a A$0.50 price target. To see the full list of analyst forecasts on Proteomics International Laboratories Ltd. stock, see the AU:PIQ Stock Forecast page.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd operates in the biotechnology industry, focusing on the development and commercialization of diagnostic tests and analytical services. The company is known for its expertise in proteomics, which involves the large-scale study of proteins, and aims to provide innovative solutions for healthcare and other industries.
Average Trading Volume: 147,943
Technical Sentiment Signal: Sell
Current Market Cap: A$56.73M
See more data about PIQ stock on TipRanks’ Stock Analysis page.